NK1.1 Cells Express 4-1BB (CDw137) Costimulatory Molecule and Are Required for Tumor Immunity Elicited by Anti-4-1BB Monoclonal Antibodies
- 1 December 1998
- journal article
- Published by Elsevier in Cellular Immunology
- Vol. 190 (2) , 167-172
- https://doi.org/10.1006/cimm.1998.1396
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- NK CELL RECEPTORSAnnual Review of Immunology, 1998
- Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand: synergy with the CD28 co-stimulatory pathwayEuropean Journal of Immunology, 1998
- Triggering of Natural Killer Cells by the Costimulatory Molecule CD80 (B7-1)Immunity, 1996
- RECEPTORS FOR HLA CLASS-I MOLECULES IN HUMAN NATURAL KILLER CELLSAnnual Review of Immunology, 1996
- Role of 4-1BB ligand in costimulation of T lymphocyte growth and its upregulation on M12 B lymphomas by cAMP.The Journal of Experimental Medicine, 1995
- Binding of diverse peptides to MHC class I molecules inhibits target cell lysis by activated natural killer cellsImmunity, 1995
- Molecular cloning of a ligand for the inducible T cell gene 4‐1BB: a member of an emerging family of cytokines with homology to tumor necrosis factorEuropean Journal of Immunology, 1993
- RAG-1-deficient mice have no mature B and T lymphocytesCell, 1992
- CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta.The Journal of Experimental Medicine, 1991
- CELL SURFACE IMMUNOGLOBULINThe Journal of Experimental Medicine, 1971